Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting.

Vijay GayamAmrendra Kumar MandalMazin KhalidOsama MukhtarArshpal GillPavani GarlapatiMowyad KhalidMohammed Mansour

Published in: International journal of hepatology (2018)

In the community care setting, Sofosbuvir based DAAs are safe, effective with high overall SVR, and well tolerated in patients with CHC patients with compensated liver cirrhosis.

Keyphrases

healthcare
hepatitis c virus
palliative care
mental health
quality improvement
hepatitis c virus infection
pain management
affordable care act
smoking cessation